Study suggests shingles vaccine may also reduce heart disease risk
A large study published in Nature Medicine suggests that the newer recombinant shingles vaccine, Shingrix, may reduce the risk of cardiovascular disease. The study, which followed over 70,000 people, found a 9% reduction in overall cardiovascular disease burden. Shingrix is the main shingles vaccine available in Malaysia for adults aged 50 and above.